Qiming Venture Partners (USA) is a venture capital and private equity firm investing in early-stage healthcare technology companies in the United States and Europe that is headquartered in Seattle, Washington and was founded in 2017 by Qiming Venture Partners. The firm also has offices in Cambridge, Massachusetts and San Francisco, California. Healthcare technology companies receiving investment from Qiming Venture Partners (USA) are typically operating in the therapeutic, digital health, or medical technology industries. Notable investments made by Qiming Venture Partners (USA) include: WindMIL Therapeutics, ZappRX, Armo Biosciences, Cadent Therapeutics, Cardialen, Kezar Life Sciences, Let's Get Checked, Madaket, My Health Teams, Nuvaira, Platelet Biogenesis, Talaris Therapeutics, and Twine Health.
CanSino Biologics (CanSinoBIO) is a bio pharmaceutical company primarily producing vaccines.
A New Zealand industrial biotechnology company developing a gas fermentation platform for converting concentrated industrial emissions into valuable chemicals.
Akulaku is an online multi-purpose finance platform intended to provide financial services to underserved communities.
A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.
A biotechnology company in Washington that focuses on developing safe and effective vaccines against infectious diseases.
Antengene is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines.
APUS is a mobile internet technology company developing and providing user system for Android tablet and smartphone users.
ZappRx is a Cambridge, Massachusetts-based health information technology company founded in 2012.